# Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

> **NCT01511848** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Beta-thalassemia Major
- Sickle Cell Disease
- Iron Hemosiderosis

## Interventions

- **DRUG:** DFP (ferriprox) and deferasirox (ICL 670)
- **DRUG:** DFP, DFO

## Key facts

- **NCT ID:** NCT01511848
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2012-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511848, "Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01511848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*